Company intelligence / Profile preview

Quinn Biopharma

Ownership: Private
Development stage: Other

Overview

Quinn Biopharma Ltd is a newly established joint venture between Quintex Pharma (Ghana) and GL Rapha Co., Ltd. (Korea), aiming to develop a state-of-the-art sterile injectable pharmaceutical manufacturing facility in Ghana. The company’s mission is to improve access to high-quality medicines across Sub-Saharan Africa by building local capacity and reducing reliance on imports. No clinical results are available, as the company focuses on manufacturing rather than R&D or clinical development at this stage

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Quintex PharmaGL Rapha Co., Ltd.Ghana Jobs and Economic Transformation ProgrammeIQVIAAMPC InternationalPwC

Beyond the preview

Go deeper on Quinn Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quinn Biopharma.

Explore the full profile